Sol Barer | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Sol Barer

Sort by

Viewing results 1‒7 of 7

European companies
New Teva chief must tackle ‘tough decisions’ on jobs
...“He understands the economic sensitivities, the pride, that it’s a big home company — and there is great sensitivity there — but you have to do what you have to do,” said Sol Barer, Teva’s chairman....
September 12, 2017
Pharmaceuticals sector
Teva’s $6bn loss complicates search for a chief
...“We will not compromise on quality and on finding the best individual possible,” said Sol Barer, chairman of Teva, who worked with Ms Fouse at Celgene....
August 3, 2017
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
European companies
Generic drug giant picks new chief after search hiccups
...Sol Barer, chairman of Teva, said Mr Schultz, a 56-year old Dane, was “the right leader to take Teva to the next level” citing his experience “executing corporate turnround strategies”....
September 11, 2017
Pharmaceuticals sector
Teva investor warns of rebellion as pressure mounts
...Teva in February parted ways with its chief executive, Erez Vigodman, and appointed Sol Barer, the veteran biotech executive, as its chairman, tasked with leading the search for the company’s third chief...
April 3, 2017
Pharmaceuticals sector
Teva says chief executive Erez Vigodman is leaving
...Israeli law requires Dr Peterburg to cede his role as chairman of the board while he serves as interim chief executive; his seat will be filled by Sol Barer, who has been a member of Teva’s board since 2015...
February 6, 2017
Personal Finance
Boardroom trades December 6
...The shares have dipped in the three weeks since chairman Sol Barer invested over £100,000 to boost his holding by 50 per cent – and he bought in again on Monday despite the weakness....
December 6, 2013
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
US & Canadian companies
Celgene to buy cancer drug group for $3bn
...Based in New Jersey and run by Sol Barer, chairman and chief executive, Celgene has seen its shares rise by about 18 per cent over the past year....
November 19, 2007

Previous pagePage 1 of 1Next page